Aflibercept intravitreal injection (EYLEA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aflibercept intravitreal injection (EYLEA), covering 2016-12-08 to 2016-12-08. Get the full timeline:
Most recent: Clinical Trial Update: NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions [Phase 4]